Advancing Treatments for Rare Eye Diseases in Europe
Restore Vision is a project funded by the European Commission aiming to develop and test new treatments for 7 rare eye diseases (REDs). The consortium joins 10 European key players on rare eye diseases and is led by University of Galway.
About Restore Vision
+30 million
people suffer from blindness and visual impairment
About Restore Vision
Over the the next 4 years (2023-2027) the Restore Vision consortium will explore new treatments for 7 REDs by repurposing existing generic drugs, developing new theurapeutic compounds, and conducting pioneering clinical trials to ensure their safety and effectiveness.
Learn more about our work
Project in numbers
0
Years (2023-2027)
0
Partners
0
EUR in funding
0
EU Countries
0
Work packages
News
Read Restore Vision’s latest news.
08 February 2024
A new eyedrop formulation of spirolactone helps corneal wound healing in rats
Learn more about Restore Vision’s preliminary results on a new eyedrop formulation.
Read more
21 December 2023
Restore Vision’s Ethics Advisor
Restore Vision is thrilled to welcome its new Ethics Advisor, Dr. Helen Busby, who will support the development and review of ethics applications for the project’s research involving human subjects.
Read more
22 September 2023
The start of Restore Vision!
The Restore Vision project has officially started! A consortium of 10 European academic, clinical and enterprise partners led by University of Galway will research and test new treatments for rare eye diseases.
Read more
Interested in Restore vision?
Restore vision is a EU-funded project working on developing new treatments for rare eye diseases. If you’re interested in collaborating or knowing more, send us a message.